Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,675,000 | 8,556,000 | 8,096,000 | 10,016,000 | 8,575,000 |
| Marketable Securities | 453,000 | 372,000 | N/A | N/A | N/A |
| Receivables | 9,643,000 | 9,828,000 | 9,230,000 | 8,571,000 | 7,843,000 |
| Inventories | 5,535,000 | 5,774,000 | 5,953,000 | 5,603,000 | 5,499,000 |
| Other current assets | 6,810,000 | 6,654,000 | 6,987,000 | 6,868,000 | 6,748,000 |
| TOTAL | $32,116,000 | $31,184,000 | $30,266,000 | $31,058,000 | $28,665,000 |
| Non-Current Assets | |||||
| PPE Net | 20,059,000 | 19,747,000 | 19,279,000 | 18,565,000 | 18,064,000 |
| Investments And Advances | 238,000 | 316,000 | 370,000 | 435,000 | 411,000 |
| Intangibles | 43,710,000 | 44,280,000 | 44,197,000 | 32,246,000 | 32,495,000 |
| Other Non-Current Assets | 10,972,000 | 11,141,000 | 11,582,000 | 11,190,000 | 11,053,000 |
| TOTAL | $74,979,000 | $75,484,000 | $75,428,000 | $62,436,000 | $62,023,000 |
| Total Assets | $107,095,000 | $106,668,000 | $105,694,000 | $93,494,000 | $90,688,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,482,000 | 3,715,000 | 4,609,000 | 3,366,000 | 3,897,000 |
| Accrued Expenses | 13,501,000 | 14,051,000 | 13,859,000 | 14,214,000 | 12,888,000 |
| TOTAL | $23,168,000 | $22,316,000 | $23,872,000 | $23,728,000 | $21,906,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,684,000 | 30,586,000 | 30,690,000 | 22,907,000 | 24,033,000 |
| Other Non-Current Liabilities | 8,946,000 | 9,745,000 | 8,996,000 | 9,465,000 | 9,871,000 |
| TOTAL | $40,609,000 | $43,399,000 | $43,565,000 | $33,903,000 | $35,394,000 |
| Total Liabilities | $63,777,000 | $65,715,000 | $67,437,000 | $57,631,000 | $57,300,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,533,280 | 2,528,805 | 2,527,734 | 2,525,944 | 2,531,375 |
| Common Shares | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 |
| Retained earnings | 58,437,000 | 56,252,000 | 53,696,000 | 51,691,000 | 48,777,000 |
| Other shareholders' equity | -4,252,000 | -4,299,000 | -4,356,000 | -4,521,000 | -4,534,000 |
| TOTAL | $43,318,000 | $40,953,000 | $38,257,000 | $35,863,000 | $33,388,000 |
| Total Liabilities And Equity | $107,095,000 | $106,668,000 | $105,694,000 | $93,494,000 | $90,688,000 |